Clinical Trial Update: Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) [Phase 3]

View source ↗

Summary

Phase 3 SENTIS trial evaluating safety and efficacy of NeuroFlo Technology in ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NeuroFlo Technology

Snippet

Sponsor: CoAxia | Conditions: Cerebrovascular Accident | Phase 3 | Status: COMPLETED